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EHV-2 induced equine keratoconjunctivitis – Evaluation of the role of immunological 
mechanisms as well as of viral and bacterial co-factors 
Several times, an involvement of the Equine Herpesvirus Type 2 (EHV-2) in different forms of 
inflammatory diseases of the cornea and/or conjunctiva in horses is documented; the exact 
pathogenesis of equine keratoconjunctivitis has yet not been understood completely. This 
project focus on the question, whether EHV-2-infected eye-diseased horses possibly show 
an immune status which differs from the reference value. Besides, the results of this thesis 
should provide conclusions, if the pathogenesis of the disease is possibly been influenced by 
immunosuppressive mechanisms of EHV-2. Furthermore, it should be investigated, whether 
other viral and/or bacterial pathogens play a role in equine keratoconjunctivitis. Finally, the 
investigations of the ocular tissue- and cell-tropism of EHV-2/-5 should further contribute to 
the understanding of the pathogenesis of this disease.        
 
Investigations of the cellular immune status had been carried out comparing ten eye-
diseased and 21 clinically sound horses. PBL, isolated from blood samples and swabs from 
the conjunctival fossa had been investigated using a EHV-2 specific nested PCR. Additio-
nally, serological investigations had been carried out and the cellular immune status of each 
horse had been determined using flow cytometry and white blood cell count methods. 
EHV-2 was detected within this study in both, eye-diseased and clinically sound horses by 
serological methods respectively nPCR. However, a statistically significant correlation bet-
ween EHV-2 and the characteristic “eye-diseased” was not observed. Referring to the cellu-
lar immune status EHV-2 positive horses without ocular diseases showed significantly more 
often decreased b-cell numbers than EHV-2 negative horses with and without ocular di-
seases, respectively. This should be seen as first indication that an EHV-2 infection or reacti-
vation causes a result in a measurable reduction of b-cells. Due to the small sample number, 
only further investigations will give information about, how individual differences of the im-
mune system may influence the outbreak of keratoconjunctivitis induced by EHV-2. 
 
To answer the question, whether other co-factors such as viral or bacterial pathogens are 
involved in EHV-2 induced equine keratoconjunctivitis, eye-swabs and blood samples from a 
second investigation group (consisting of 68 eye-diseased and 32 clinically sound horses) 
had been tested for EHV-2 and subsequently EHV-5, using specific nPCRs. Finally, random 
samples of eye-swabs had been investigated using pathogen specific PCRs for the presence 
of EAdV-1, chlamydiae and mycoplasmae, respectively. Within the scope of this project, the  
EAdV-1 specific nPCR had been established previously. 
Summary 
A statistically significant correlation between eye-diseased and sound horses relating to the 
detection rate of EHV-2 in swab- and blood-samples was also not observed in this investiga-
tion group. In addition, evidence for an involvement of EAdV-1, chlamydiae and mycoplas-
mae, respectively in inflammatory diseases of the cornea and/or conjunctiva of horses could 
not been deduced. However, it is very likely that EHV-5 is involved in the pathogenesis of 
equine keratoconjunctivitis as EHV-5-genom was detected frequently in diseased eyes com-
pared with EHV-2, even though there was no observation of a significant correlation between 
the characteristic “eye-diseased”. 
 
Studies about the tissue- and cell-tropism had been carried out on various ocular tissues 
(conjunctiva, cornea, nervus opticus and retina) as well as on cytobrush-swabs, which had all 
been taken post mortem from 14 healthy slaughtered horses. The genome of EHV-2 and -5 
had been detected in cytobrush samples and in the conjunctiva only, even though the detec-
tion rate was very low (proportion of EHV-2 resp. -5 positive swabs:  11% in each case; pro-
portion of EHV-2 resp. -5 positive conjunctiva: 7 resp. 8%).  
Finally, the exemplary investigation of a EHV-2-nPCR positive conjunctiva of one horse using 
the in-situ hybridisation, a method that had been established within the scope of this project 
revealed, that EHV-2 DNA is present in the submucosa of the conjunctiva palpebralis. Thus, 
specific cells of the immune system might possibly be a site of latency within this tissue.    
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